Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E24.18 EPS (ttm)5.48 Insider Own0.10% Shs Outstand2.69B Perf Week0.98%
Market Cap356.47B Forward P/E15.46 EPS next Y8.57 Insider Trans-5.46% Shs Float2.68B Perf Month3.66%
Income14.97B PEG3.14 EPS next Q2.03 Inst Own68.20% Short Float0.56% Perf Quarter6.97%
Sales80.68B P/S4.42 EPS this Y-8.50% Inst Trans0.13% Short Ratio2.29 Perf Half Y0.95%
Book/sh23.45 P/B5.65 EPS next Y5.26% ROA0.90% Target Price143.35 Perf Year-1.26%
Cash/sh6.74 P/C19.65 EPS next 5Y7.70% ROE2.10% 52W Range118.62 - 148.32 Perf YTD-5.18%
Dividend3.60 P/FCF38.27 EPS past 5Y7.10% ROI15.70% 52W High-10.40% Beta0.68
Dividend %2.72% Quick Ratio1.30 Sales past 5Y2.60% Gross Margin65.80% 52W Low12.04% ATR1.68
Employees134000 Current Ratio1.70 Sales Q/Q10.60% Oper. Margin22.10% RSI (14)64.87 Volatility1.18% 1.12%
OptionableYes Debt/Eq0.51 EPS Q/Q4.10% Profit Margin1.70% Rel Volume0.81 Prev Close132.48
ShortableYes LT Debt/Eq0.47 EarningsJul 17 BMO Payout572.60% Avg Volume6.51M Price132.90
Recom2.30 SMA201.76% SMA505.00% SMA2000.84% Volume1,086,733 Change0.32%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Aug-17-18 09:34AM  Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication Zacks
04:24AM  Glaxo, J&J's Dual Drug HIV Regimen Succeeds in Phase III Study Zacks
Aug-16-18 02:18PM  HBJ health care panel talks tech innovation, high patient costs American City Business Journals
01:53PM  Trump administration proposes production quota cuts for six opioids Reuters
09:59AM  Why Is Johnson & Johnson (JNJ) Up 1% Since Its Last Earnings Report? Zacks
08:44AM  Better Speculative Biotech Stock: Amarin Corporation vs. Geron Corporation Motley Fool
07:19AM  Should Gilead Be Worried About This New Monthly HIV Medication? Motley Fool
Aug-15-18 05:49PM  Rare Genetic Mutation May Help Drugmakers Battle Obesity Bloomberg Video
12:00PM  A Rare Genetic Aversion to Sweets Could Be Key to Fighting Obesity Bloomberg
Aug-14-18 12:27PM  SurveyMonkey adds Emory dean to board of directors, balancing its gender representation American City Business Journals
06:01AM  Better Buy: AbbVie Inc. vs. Johnson & Johnson Motley Fool
Aug-13-18 02:39PM  Jury orders Monsanto to pay $289 million in Roundup cance... CNBC Videos
02:18PM  The Philosophy of Dividend Aristocrat Stocks InvestorPlace
02:12PM  Buy Johnson & Johnson, Now Poised to Rally
12:36PM  Shire, Shionogi File NDA for Intuniv for Adults in Japan Zacks
08:17AM  3 Biotech Stocks With Major Catalysts Incoming Motley Fool
07:38AM  The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers Zacks
Aug-10-18 11:37AM  3 Reasons Cisco Systems Stock Can Surge to $50 InvestorPlace
08:52AM  Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus Zacks
Aug-09-18 05:18PM  Factbox: U.S. companies with exposure to Russia Reuters
02:08PM  Generic Drugmakers Struggle Despite U.S. Push for Copycats Bloomberg
Aug-08-18 05:30PM  Johnson & Johnson Announces Chris DelOrefice as Vice President of Investor Relations PR Newswire
02:41PM  NYSE trader: Stocks could drop in August Yahoo Finance Video
Aug-07-18 02:04PM  Johnson & Johnson to Participate in the 2018 Wells Fargo 13th Annual Healthcare Conference PR Newswire
01:56PM  Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference PR Newswire
10:26AM  Trump seeks out business leaders as midterm election looms Reuters
09:50AM  Q2 Earnings Drive Pharma ETFs Higher Zacks
Aug-06-18 04:07PM  Daabon Strikes Deal With Avicanna, Becoming The Largest Agro Company To Enter The Cannabis Industry Benzinga
02:30PM  3 Reasons Geron Corporation Stock Could Be a Big Winner Motley Fool
07:28AM  Drug distributor Cardinal's profit beats on pharma unit strength Reuters
Aug-05-18 07:42PM  How China Is Evolving From a Maker of Copycat Medicines Into a Producer of Complex Drugs The Wall Street Journal
08:00AM  J&J Bets on Chinese Startup That Uses Llama DNA to Fight Cancer The Wall Street Journal
Aug-04-18 12:00PM  The 4 Cheapest 'Dividend Kings' to Buy Today
Aug-02-18 04:13PM  Missouri governments sue drug companies over opioid epidemic American City Business Journals
02:06PM  WHO sees complex vaccine and security questions in Ebola response Reuters
12:35PM  Theravance Biopharma (TBPH) Q2 Loss Narrows, Shares Up Zacks
10:00AM  Cosmetics avoided strict regulation for over a century. Rising health concerns has FDA inquiring. CNBC
06:32AM  Better Buy: Johnson & Johnson vs. Pfizer Motley Fool
Aug-01-18 04:48PM  Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down Zacks
04:12PM  Why The 'Heat Wave' For U.S. Pharma Could Continue This Month Investor's Business Daily
03:08PM  NYSE trader: American wealth and stock earnings are at record highs, so I can only be bullish Yahoo Finance Video
Jul-31-18 08:58PM  U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict Reuters
07:21PM  U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict Reuters
06:57PM  U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict Reuters
02:27PM  Pfizer CEO expects Trump to eliminate drug rebates Reuters
Jul-30-18 07:44PM  [$$] Johnson & Johnson Adds Zarbees Naturals to Bolster Consumer Brands The Wall Street Journal
12:50PM  [$$] Johnson & Johnson Adds Zarbee's Naturals to Bolster Consumer Brands The Wall Street Journal
Jul-27-18 06:58PM  All New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 7/27/18)
03:46PM  NYSE trader: Consumers are slowly retrenching because of trade uncertainty Yahoo Finance Video
11:53AM  Collaborations Help Alkermes Flip to Profitability Motley Fool
02:45AM  Pharma Favorites: 7 Healthy Picks in the Drug Sector Investopedia
Jul-26-18 11:46AM  Fight Inflation With Prudent Stock Market Investing InvestorPlace
09:59AM  5 Dow Jones Stocks That Are Ready to Rise Again InvestorPlace
08:57AM  3 Stocks That Could Double Your Money Motley Fool
Jul-25-18 06:21PM  3 Great Stocks for Retirees to Own
01:20PM  Understanding the Components and the Concept of Alpha InvestorPlace
10:51AM  The Top 4 UPS Shareholders (UPS) Investopedia
07:00AM  Did This Top Biotech Stock Just Go on Sale? Motley Fool
Jul-24-18 10:56AM  Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings? Zacks
08:37AM  Pharma/Biotech Stock Q2 Earnings on Jul 25: GILD, VRTX & GSK Zacks
08:36AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical Zacks
Jul-23-18 03:07PM  Johnson & Johnson Is a Great Company, But Be Patient
01:30PM  MARKETS: Why Trump is talking down bonds and the dollar, but stocks are just shrugging Yahoo Finance Video
11:09AM  Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger Zacks
Jul-22-18 10:47AM  Here's Why Big Pharma Loves This Plan to Lower Drug Prices Motley Fool
Jul-20-18 11:16AM  MARKETS: Honeywell stock pops after raising full year guidance Yahoo Finance Video
09:21AM  3 Stocks That Could Be Added to the Dow Next Motley Fool
08:59AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals Zacks
07:55AM  Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress Zacks
07:30AM  Three Key Takeaways From Healthcare Earnings Season
Jul-19-18 09:07PM  Women who sued Johnson & Johnson declare victory after $4.69 billion talc verdict Reuters
03:06PM  Women who sued J&J declare victory after $4.69 billion talc verdict Reuters
02:58PM  Johnson & Johnson and General Motors: Growth and Income Stocks Zacks
02:46PM  Women who sued J&J declare victory after $4.69 bln talc verdict Reuters
02:29PM  These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories Motley Fool
01:03PM  Edited Transcript of JNJ earnings conference call or presentation 17-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
10:14AM  AbbVie shares drop 5.5% after short seller Citron calls it 'next great drug short' MarketWatch
09:36AM  Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson? Motley Fool
07:34AM  Free Research Report as Johnson & Johnson's Quarterly Earnings Advanced 14.75% ACCESSWIRE
Jul-18-18 09:12PM  New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock InvestorPlace
05:57PM  J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod Zacks
10:05AM  Healthcare ETFs in Focus Following JNJ Q2 Results Zacks
09:56AM  Penn, Johnson & Johnson team up to accelerate innovation American City Business Journals
09:53AM  Stock Market News For Jul 18, 2018 Zacks
09:44AM  Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares
08:42AM  Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares Benzinga
08:10AM  Today's Research Reports on Stocks to Watch: Johnson & Johnson and Avid Bioservices ACCESSWIRE
03:39AM  J&J (JNJ) Faces $4.69 Billion Verdict in Talc Case (Revised) Zacks
Jul-17-18 11:41PM  Asian stocks rise as solid US performance lifts spirits Associated Press
10:49PM  [$$] Johnson & Johnsons Pharma Business Fuels Sales Growth The Wall Street Journal
10:13PM  Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch Zacks
09:31PM  What's Behind Johnson & Johnson's Double-Digit Growth? Motley Fool
07:01PM  Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups
05:37PM  British pharma company Eusa set to unveil deal with giant Johnson & Johnson The Telegraph
05:29PM  What Happened in the Stock Market Today Motley Fool
05:12PM  After the Bell: Dow Rises 56 Points as Stocks Keep Chugging Higher
04:52PM  US companies are shipping goods before they're hit with tariffs: report Fox Business Videos
04:50PM  MedPlast Holdings, Inc. -- Moody's assigns B2 CFR to MedPlast Holdings, Inc. Moody's
04:42PM  Johnson & Johnson climbs while Netflix and UnitedHealth slip Associated Press
04:39PM  US STOCKS-Wall St climbs on Powell comments, earnings Reuters
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM